P104 - Stereotactic body radiation therapy and abiraterone acetate for patients affected by oligometastatic castrate-resistant prostate cancer: Freedom from biochemical, radiological progression free survival and freedom from following treatment approaches within a randomized phase II trial (ARTO – NCT03449719)
| Autor: | Francolini, G., Detti, B., Di Cataldo, V., Caini, S., Bruni, A., Ingrosso, G., D’angelillo, R.M., Alitto, A.R., Augugliaro, M., Triggiani, L., Parisi, S., Facchini, G., Banini, M., Simontacchi, G., Desideri, I., Meattini, I., Frosini, G., Burchini, L., Marvaso, G., Alongi, F., Arcidiacono, F., Lancia, A., Genovesi, D., Franzese, C., Timon, G., Tagliagambe, A., Livi, L. |
|---|---|
| Zdroj: | In European Urology Open Science November 2023 57 Supplement 1:S157-S158 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|